JPRN-UMIN000009908已完成未知
In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safety - In combination therapy with insulin and DPP-4 inhibitor sitagliptin Study of efficacy and safety
Diabetes Center,Tokyo Women's Medical University0 个研究点目标入组 50 人开始时间: 2013年1月30日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Medical history of hypersensitivity to sitagliptin Age below 20years old at the time of obtaining consent Judgment of ineligibility to be a subject by the principle investigator
研究者
相似试验
已完成
不适用
Insulin combined with the DPP-4 inhibitor sitagliptin for diabetes: evaluation studyType2 diabetesJPRN-UMIN000011346Japan Association for Diabetes Education and Care10,000
已完成
不适用
Effect of DPP-4 inhibitor on insulin therapy for patients with type 2 diabetesType 2 diabetesJPRN-UMIN000006470Jikei University School of Medicine Kashiwa Hospital20
已完成
不适用
Effect of combination therapy with DPP-4 inhibitor and omega 3-fatty acid on glycemic control in type2 diabetes with dyslipidemiaType 2 diabetes mellitusJPRN-UMIN000010397Yokohama City University Medical Center150
已完成
不适用
Effect of DPP-4 inhibitor or Metformin on insulin therapy in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000008155Divison of Diabetes and Metabolism,Itabashi Hospital, Nihon University School of Medicine40
已完成
不适用
Efficacy of combination therapy of DPP-4 inhibitor and alpha glucosidase inhibitor in insurin treaaed type 2 diabetes.Type 2 diabetesJPRN-UMIN000011815ational Center for Global Health and Medicine5